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Background: Chorismate mutase (CM) catalyzes the Claisen rearrangement of
chorismate to prephenate, notably the only known enzymatically catalyzed
pericyclic reaction in primary metabolism. Structures of the enzyme in complex
with an endo-oxabicyclic transition state analogue inhibitor, previously
determined for Bacillus subtilis and Escherichia coli CM, provide structural
insight into the enzyme mechanism. In contrast to these bacterial CMs, yeast
CM is allosterically regulated in two ways: activation by tryptophan and
inhibition by tyrosine. Yeast CM exists in two allosteric states, R (active) and T
(inactive).
Results: We have determined crystal structures of wild-type yeast CM co-
crystallized with tryptophan and an endo-oxabicyclic transition state analogue
inhibitor, of wild-type yeast CM co-crystallized with tyrosine and the endo-
oxabicyclic transition state analogue inhibitor and of the Thr226→Ser mutant of
yeast CM in complex with tryptophan. Binding of the transition state analogue
inhibitor to CM keeps the enzyme in a ‘super R’ state, even if the inhibitory
effector tyrosine is bound to the regulatory site.
Conclusions:  The endo-oxabicyclic inhibitor binds to yeast CM in a similar
way as it does to the distantly related CM from E. coli. The inhibitor-binding
mode supports a mechanism by which polar sidechains of the enzyme bind
the substrate in the pseudo-diaxial conformation, which is required for
catalytic turnover. A lysine and a protonated glutamate sidechain have a
critical role in the stabilization of the transition state of the pericyclic reaction.
The allosteric transition from T→R state is accompanied by a 15° rotation of
one of the two subunits relative to the other (where 0° rotation defines the T
state). This rotation causes conformational changes at the dimer interface
which are transmitted to the active site. An allosteric pathway is proposed to
include residues Phe28, Asp24 and Glu23, which move toward the active-
site cavity in the T state. In the presence of the transition-state analogue a
super R state is formed, which is characterised by a 22° rotation of one
subunit relative to the other. 
Introduction
Chorismic acid lies at the first branch point of the biosyn-
thetic pathway of the aromatic amino acids tryptophan,
phenylalanine and tyrosine (Figure 1; [1,2]). In one branch,
which leads to the production of tryptophan, chorismate is
the substrate of the heterodimeric enzyme anthranilate
synthase. In the other branch, chorismate mutase (CM,
chorismate pyruvatemutase; E.C. 5.4.99.5) catalyzes the
intramolecular rearrangement of chorismate to prephen-
ate, the first committed step in the synthesis of tyrosine
and phenylalanine. In the yeast Saccharomyces cerevisiae,
the activity of CM is modulated by a ~tenfold activation
by tryptophan and a ~tenfold feedback inhibition by tyro-
sine [3]. The 100-fold modulation of the enzyme activity
by these two amino acids controls the flux of chorismic
acid into the phenylalanine/tyrosine-biosynthetic branch
in relation to the tryptophan branch, where anthranilate
synthase competes with chorismate mutase for the common
substrate. Activation and inhibition are mainly caused by
a change in Km along with relatively small changes in kcat.
The active R form of CM has a pH optimum of 6.5,
whereas optimum activity is seen at pH 5.0 in the inac-
tive T form.
Yeast CM (YCM) is a homodimer of two 30 kDa polypep-
tides. As a relatively small protein in the allosteric family,
YCM provides an ideal system for exploring the detailed
mechanisms of allosteric regulation. Crystal structures of
YCM have been determined for the Thr226→Ile mutant
[4], which is trapped in the active R state, and for the
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tyrosine-bound wild-type enzyme in the T state [5]. A com-
parison of these structures showed that the allosteric transi-
tion includes a 15° rotation of one of the two catalytic
domains relative to the other. It was also demonstrated that
both allosteric effectors, tryptophan and tyrosine, bind to
the same binding site at the dimer interface. Although dif-
ferences were apparent between the active sites in the R
state and in the T state structures, it was yet difficult to
relate these changes to the modulation of enzyme activity
because detailed structural information on the binding
mode of the substrate or transition state was not available.
The catalysis of a pericyclic reaction by chorismate mutase
has stimulated many biochemical, computational and
structural studies (reviewed in [6]). Molecular orbital cal-
culations [7,8] and studies of isotope effects using labeled
substrate [9,10] indicate that, in both the uncatalyzed and
catalyzed reactions, the rearrangement of chorismate to
prephenate  proceeds through a transition state with chair-
like geometry. In solution, 10–20% of chorismate exists in
the energetically less favored pseudo-diaxial form in
dynamic equilibrium with the pseudo-diequatorial form
(Figure 1; [11]). It has thus been proposed that the reac-
tion is accelerated by binding of the active diaxial con-
former to the enzyme [12]. Catalysis of the [3,3]-sigma-
tropic rearrangement might proceed by attack of an
enzyme nucleophile at C5 leading to the formation of an
intermediate [10], or in a concerted but perhaps asynchro-
nous pericyclic process like the uncatalyzed reaction [13].
Rate enhancement of the pericyclic reaction was proposed
to be achieved by electrostatic stabilization of the transi-
tion state [13], which might have a dipolar character after
heterolytic cleavage of the C–O bond. Strong binding of
an endo-oxabicyclic transition-state analog [14] suggests
that the enzyme-catalyzed reaction may proceed via a
similar transition state.
Detailed structural insight into the mechanism of these
enzymes was first obtained by structure determinations of
Bacillus subtilis CM in the unligated form, in complex with
the product prephenate and in complex with the endo-
oxabicyclic transition-state analog (Figure 1; [15,16]). Later,
the X-ray structure of YCM was determined for the acti-
vated R state [4]. More recently, the structure of the CM
domain of the P protein from Escherichia coli was deter-
mined with the transition state analogue inhibitor bound to
the active site, and it was found to be related to YCM [17].
On the basis of this relationship to E. coli CM, the active
site in YCM could be located [18]. The active-site cavity in
E. coli CM is surrounded by a four-helix bundle which can
be superimposed onto a similar helix bundle in YCM,
yielding 22% sequence identity of 94 residues. Mutational
analysis of all critical active-site residues in YCM con-
firmed the proposed location of the active site and quanti-
fied their contribution to catalysis [19].
The endo-oxabicyclic transition-state analogue has also
been used to generate antibodies that have CM activity.
The crystal structure of one of these catalytic antibodies
(1F7), which achieves a 250-fold rate enhancement over
the uncatalyzed reaction, is available in complex with the
endo-oxabicyclic inhibitor [20]. The most active abzyme,
11F1–2E11, gave a 104-fold rate enhancement compared
to a ~106-fold rate acceleration by the wild-type enzymes
[21]. The known CM structures, except that of YCM,
have been discussed previously [22].
Here, we present two crystal structures of YCM in complex
with an endo-oxabicyclic transition-state analogue and with
either the allosteric activator tryptophan (ITRP) or the
allosteric inhibitor tyrosine (ITYR). Also, a high resolution
crystal structure of the tryptophan-bound R form of the
Thr226→Ser mutant of YCM (STRP) is presented in space
1438 Structure 1997, Vol 5 No 11
Figure 1
Conversion of chorismate to prephenate by
chorismate mutase in relation to the
biosynthesis of aromatic amino acids. Also
shown are two conformers of chorismate, the
transition state of the pericyclic reaction and
an endo-oxabicyclic transition state analogue
inhibitor.
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group C2. The three new structures are compared with the
structures of wild-type YCM in the T state, the Thr226→
Ile mutant of YCM in the R state and the structures of B.
subtilis and E. coli CM. Together, these structures support a
mechanism by which polar sidechains of the enzyme bind
the substrate in the pseudo-diaxial conformation, which is
required for catalytic turnover via a pericyclic reaction
pathway. A lysine and a protonated glutamate sidechain
have a critical role in the stabilization of the transition state
of the pericyclic reaction. An analysis of the structures in
different allosteric states shows that the allosteric transition
is accompanied by a rotation of the two subunits relative to
each other. This rotation causes conformational changes at
the dimer interface where Phe28 and Tyr212 interact. A
detailed allosteric pathway is proposed to include these
sidechains as well as Asp24, Lys208, Arg204, and Glu23,
which transmit the allosteric signal to the active site.
Results
Enzyme structure
YCM is essentially an all-helix structure; each monomer
has 12 helices, of which four (H1, H3, H5 and H6) contain
only one turn. The longer helices are shown with labels in
Figure 2. H8, the longest helix, contains 32 residues and
spans the whole monomer; it also connects the catalytic
site with the regulatory site. The active site is located
between helices H2, H8, H11 and H12, which together
with helices H7 H9, and H10 form the catalytic domain.
Helix H4 and loops L50s (residues 44–58) and L80s
(residues 79–107) are part of the regulatory domain. The
two allosteric effectors bind to the regulatory site at the
dimer interface. On one side this site has helix H8 of one
monomer, whereas on the other side the second monomer
supplies the 80s loop and helices H4 and H5. Dimeric
YCM has dimensions of 90 × 55 × 55 Å. A strong hydropho-
bic association between the monomers at the dimer inter-
face is mediated by helices H2, H4, H8 and H11. Also the
loops L80s and L50s of the regulatory domain participate
in inter-subunit interactions.
To facilitate the following description of our results and
discussion, which depends on comparisons of different
structures, Table 1 summarizes the main characteristics of
the structures discussed in this article and gives abbrevia-
tions which are used in the following text.
The active site and inhibitor binding
Binding of the endo-oxabicyclic inhibitor to the presumed
[18] active-site pocket was clearly demonstrated by the
electron density maps (Figure 3a). Due to the compact
shape of the bicyclic structure of the inhibitor, the elec-
tron density had roughly a spherical shape at the rela-
tively low resolution of the data. The lobes caused by 
the inhibitor’s carboxylate and hydroxyl groups, however,
were clearly visible even before the inhibitor was intro-
duced into the model and helped to determine the orien-
tation of the inhibitor. This binding mode of the
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Figure 2
Structure of the YCM dimer. The catalytic domains are colored yellow
and red, the regulatory domains cyan and purple. Shown in green are
the endo-oxabicyclic inhibitor (I) bound to the active sites and
tryptophan bound at the regulatory sites. The view is along the
allosteric rotation axis perpendicular to the dimer axis (both axes
shown in black). The rotation along the allosteric axis (represented by a
filled circle) from the T to the R state is such that the catalytic domain
of the left subunit rotates clockwise and that of the right subunit
counter-clockwise (see also Figure 9).
Table 1
Characteristics of the structures discussed in this article.
Structure Protein Ligands State Space group Resolution (Å) pH PDB code Reference
TRP T226I tryptophan R P61 2.2 8.0 1csm [4]
TYR wild type tyrosine T P43212 2.8 5.0 2csm [5]
ITRP wild type inhibitor + tryptophan super R R32 3.0 8.0 3csm this study
ITYR wild type inhibitor + tyrosine super R R32 2.8 9.0 4csm this study
STRP T226S tryptophan R C2 2.0 5.0 5csm this study
transition-state analogue (Figure 3) confirms the model for
inhibitor binding, which was proposed on the basis of the
homology of YCM to E. coli CM [18].
Interestingly, the structures of the active sites are practi-
cally identical in ITRP (YCM in complex with the
inhibitor and tryptophan) and ITYR (bound inhibitor
and tyrosine). All polar sidechains of the active sites 
have very similar conformations and positions. Only the
hydrophobic sidechains of Ile239 and Ile192 have been
refined to different conformations of the χ1 and χ2
torsion angles, respectively; however, these sidechains
still have similar positions.
The guanidinium groups of Arg16 and Arg157 bind the two
carboxylate groups of the inhibitor, whereas its hydroxyl
group is hydrogen bonded to the sidechain of Glu198 and to
the backbone NH group of Asn194 (Figure 3). Lys168 and
Glu246 are in hydrogen-bonding distance to the ether
oxygen O7 of the inhibitor. In addition, hydrophobic con-
tacts with Leu19, Leu12, Val164, Val197, Ile239 and the
sidechain carbons of Lys243 contribute to inhibitor binding.
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Figure 3
Binding mode of the endo-oxabicyclic inhibitor
to the active site. (a) 2.8 Å Fo–Fc difference
electron density of the inhibitor in ITYR. Also
shown are the sidechains of those residues
which have polar interactions with the
inhibitor. (b) Scheme of interactions between
the inhibitor and active site residues of YCM.
(c) Stereo view of the binding mode of the
inhibitor to the active site in ITRP. (d,e)
Binding of the endo-oxabicyclic inhibitor to
E. coli CM (d) and to B. subtilis CM (e). All
proton positions in (b) are inferred. Pending
identification of pKas, mechanisms are
possible in which the carboxylate group of
Glu246 is ionized.
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Structure
All active-site sidechains are well defined in the electron-
density maps (data not shown). The close distance of
2.8 Å between the carboxylate group of Glu246 and the
inhibitor’s ether oxygen suggests that this sidechain is pro-
tonated, despite the relatively high pH value at which the
crystals were obtained (pH 8–9). Protonation at high pH
values is supported by the pH rate profile for the R-state
enzyme, which has maximum activity at pH 7.0 and shows
around 30% activity at pH 9.0 [3]. In the tryptophan-acti-
vated enzyme (ITRP), the distances from the inhibitor’s
ether oxygen atom to Oε1 and Oε2 of Glu246 are both rela-
tively long (3.1 and 3.2 Å, respectively). At the resolution of
the present study, however, the sidechain positions are not
that accurately defined and it is possible that one oxygen,
which may be protonated, is actually closer to the ether
oxygen of the inhibitor, similar to the situation in ITYR
(distances of 3.3 and 2.8 Å between the ether oxygen of the
inhibitor and Oε1 and Oε2 of Glu246).
Superposition of the different allosteric states
Figure 4 shows a superposition of the five structures that
have been determined for YCM. Atoms of only one
monomer (shown in the upper half of Figure 4) were used
to calculate the matrix for this superposition. As outlined in
the introduction, the allosteric transition is accompanied by
a rotation of the two subunits relative to each other. Thus,
differences seen in the other monomer in Figure 4 (lower
half) are mainly due to different allosteric states. Not sur-
prisingly, the T-state structure TYR (black) is most dif-
ferent from all other structures. The structures of STRP
(green), the Thr226→Ser mutant in complex with trypto-
phan, and TRP (blue), the previously determined R-state
structure, are similar to each other. Interestingly, ITRP
(red) as well as ITYR (yellow) are even more different from
the T-state than the R-state structures (TRP and STRP).
Not only are the structures of the active site in ITRP and
ITYR very similar (see previous section), the catalytic
domains of these two structures also superimpose closely
(Figure 4). After the two structures have been superim-
posed on the basis of the catalytic domain of one subunit,
the catalytic domain of the other subunit is aligned as well.
This surprising result demonstrates that both structures are
in the same allosteric R-like state even though tyrosine (an
allosteric inhibitor) is bound to ITYR. The active-site
inhibitor keeps the enzyme tightly locked in a state which
is in the direction of the T→R transition even beyond
TRP, the tryptophan-activated R state. This novel struc-
ture may thus be designated a ‘super R’ state. The only sig-
nificant differences between ITRP and ITYR are seen in
the regulatory domain, which has moved toward the T state
in ITYR, but is not identical to it (see below).
The structural differences related to the allosteric transi-
tion may be quantified by using all atoms of the dimer in
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Figure 4
Superposition of the five YCM structures in
different allosteric states. Superimposed on
the basis of the Cα atoms of monomer A
(upper half) are TYR (black), TRP (blue),
STRP (green), ITRP (red) and ITYR (yellow).
Monomer B is shown in lower half of figure;
see Table 1 for descriptions of different YCM
structures. Also shown is tryptophan bound to
the allosteric site.
Structure
a superposition to calculate a root mean square (rms)
deviation. TYR differs from ITRP as well as ITYR by
the maximum value of 3.2 Å. STRP and TRP, which
have rms differences from TYR of 2.5 and 2.4 Å, respec-
tively, are somewhat closer to the T state. ITYR and
ITRP differ by 0.7 Å, STRP and TRP by 0.5 Å. Another
way to quantify the differences between the allosteric
states is using the angle by which the monomers rotate
relative to each other around the allosteric rotation axis
in the T→R transition. This rotation angle relative to
TYR is 22.0° and 21.7° for the super R state structures
ITRP and ITYR, whereas rotations relative to TYR of
14.8° and 16.2° characterize the R state structures TRP
and STRP, respectively. The axis of rotation is perpen-
dicular to the dimer axis (twofold rotation axis relating
the two subunits) as shown in Figure 2. The direction of
the rotation is such that if the right monomer in Figure 2
(shown in yellow) is fixed, the other monomer rotates
clockwise in the T→R transition.
The allosteric transition is also accompanied by smaller
changes within the catalytic domain, which account for the
lower or impaired activity of the T state. The rms differ-
ences between the catalytic domains (calculated after
superposition of these domains) correlate with those devi-
ations between the dimers — the structures which are
most different along the allosteric transition also show
more changes within their catalytic domains. Again, the
catalytic domain of the T-state structure TYR is more dif-
ferent from ITRP and ITYR (both having an rms devia-
tion of 1.4 Å) than from R-state structures TRP and STRP
(1.1 and 1.2 Å, respectively).
The regulatory site
The 2.0 Å structure of STRP provides a detailed picture
of the structure of the regulatory site in the R state. Tryp-
tophan has four direct polar interactions with residues of
helix H8 (Figure 5a; Table 2), but it has only hydrophobic
contacts to H4/H5 of the other subunit, mainly between
its six-membered ring and Ile74. In addition, tryptophan is
hydrogen bonded to five water molecules: the carboxylate
group interacts with three water molecules, the amino
group with one water molecule and the sidechain nitrogen
with another (for clarity water molecules are not shown in
Figure 5). The binding mode of tryptophan and the struc-
ture of the regulatory site show no significant differences
between ITRP, TRP and STRP.
A superposition of ITYR with T- and R-state structures
showed that ITYR is in the active R state (see above).
Difference electron-density maps, however, clearly demon-
strated that the allosteric inhibitor tyrosine, which was
present in the crystallization buffer at a concentration of
2 mM, is bound to the regulatory site (Figure 5b). The
density of the effector was well defined and the
sidechain had the shape of the phenol group of tyrosine,
but not that of the larger tryptophan sidechain. As a
result of the binding of the allosteric inhibitor, tyrosine,
to the R-state structure of the enzyme, the regulatory
site in ITYR has a structure which is between that in the
R state and that in the T state (Figure 5; Table 2).
Although Arg75 and Arg76 have polar interactions with
the tyrosine ligand which are characteristic of the T state
[5], a superposition of the regulatory sites in TYR and
ITYR shows differences in mainchain and sidechain
positions of the protein and the inhibitor (Figure 4d).
The sidechain of Arg75, in particular, is not properly
positioned to have as favorable hydrogen-bonding inter-
actions as seen in the T state. Also, the guanidinium
group of Arg76 in ITYR is (despite a similar hydrogen-
bonding distance) not as well oriented for a hydrogen-
bonding interaction with the allosteric inhibitor as it is in
TYR (Figure 5d).
A superposition of the regulatory sites in ITYR and
ITRP demonstrates significant differences in this region
(Figure 5c). The hydrophobic contact between the six-
membered ring of tryptophan and Ile74 pushes the 80s
loop apart from helix H8 of the other subunit. In ITYR,
this loop is closer to the effector and Arg75 interacts with
the carboxylate group of tyrosine. Maximum differences
around 2–3 Å are present in the position of some residues
of the 80s loop between ITYR and ITRP. Thus, there are
differences in the region around the regulatory site in
ITYR from that of TYR as well as ITRP.
The 220s loop and amino acid 226
Mutations of Thr226 significantly influence the allosteric
behavior of YCM. Various replacements of Thr226 have
been characterized kinetically, showing that these muta-
tions shift the enzyme toward the R state to different
degrees [23]. The Thr226→Ile mutant, for which the
first structure of the enzyme was determined (TRP; [4]),
is locked in the R state. In the tyrosine-bound T-state
structure of wild-type YCM (TYR), the sidechain of
Thr226 may be hydrogen bonded to either the carboxy-
late group of Glu228 or to the backbone carbonyl group
of Arg224 via a water molecule [5]. Amino acid 226 is at
the connection between helix H12 and the 220s loop,
which is largely disordered in all four crystal forms of
YCM. The disordered region comprises residues 218–221
in TRP, ITRP and ITYR, 215–223 in TYR and 218–223
in STRP. Those residues of this loop (212–226) that are
visible in the electron-density maps, however, indicate
that the position of this loop changes significantly during
the allosteric transition.
The allosteric behavior of the Thr226→Ser mutant, the
structure of which is described here, is also shifted
toward the R state, although less than in other Thr226
mutants [23]. The hydroxyl group of the sidechain of
Ser226 in STRP is hydrogen bonded to the backbone
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NH group of Glu228. Although structures of two mutants
carrying amino acid replacements at position 226 are
known in addition to the wild-type enzyme structure, it
remains difficult to explain the role of this residue and the
220s loop in the allosteric transition. The most likely
explanation is that if large sidechains are present at posi-
tion 226, the 220s loop is sterically prevented from gaining
a conformation which is necessary for the formation of the
T state. This suggestion, however, does not account for
the stronger tyrosine inhibition of the wild-type enzyme
than that of the Thr226→Ser mutant. Mutations or dele-
tions of the other residues of the 220s loop might probe
the significance of this partially disordered loop in the
allosteric transition. Further indication of the importance
of this loop arises from the analysis of a proposed allosteric
pathway (see below).
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Figure 5
Structure of the regulatory binding site. 
(a) Fo–Fc difference electron density map of
tryptophan bound to the regulatory site in
STRP. (b) Fo–Fc difference electron density
map of tyrosine bound to ITYR. (c)
Superposition of ITYR (green) and ITRP
(yellow) based on the Cα atoms of the
catalytic domain (see Materials and methods).
(d) Superposition of ITYR (green) and TYR
(yellow) based on the Cα atoms of residues
133–152. Nitrogen atoms are colored blue
and oxygens red.
Discussion
Comparison to other chorismate mutases
As a result of the conserved active-site pockets, the
binding mode of the endo-oxabicyclic inhibitor in YCM is
very similar to that in E. coli CM [17] (Figures 3b, 3d and
6a). The major difference between the two enzymes is
the presence of Glu246 in the active site of YCM,
whereas E. coli CM displays a corresponding glutamine
(Gln88). Gln88 is hydrogen bonded to the ether oxygen
of the inhibitor and obviously has an important role in
the enzyme mechanism. Another difference is that the
sidechain of YCM residue Thr242 was refined to a con-
formation in which the hydroxyl group is not hydrogen
bonded to the C10 carboxyl group of the inhibitor, con-
trary to what might be expected from an analogous inter-
action of Ser84 of E. coli CM with the inhibitor (Figure 3d).
Thr242 instead interacts with the backbone carbonyl
group of Val238; however, Thr242 is essential for YCM
activity [19].
In B. subtilis CM, the inhibitor has similar polar inter-
actions with the enzyme [15,16]. Here, the guanidinium
group of Arg90 is hydrogen bonded to the ether O7
oxygen atom of the inhibitor (Figure 3e). In B. subtilis CM,
the inhibitor interacts through one of its carboxylate
groups with Arg7 and its hydroxyl group with Glu78,
similar to interactions in YCM and E. coli CM; however,
the polar interactions between the second carboxylate
group of the inhibitor and the protein are absent in B. sub-
tilis CM. The active site of B. subtilis CM is somewhat
open and more solvent accessible than the more buried
catalytic pockets in YCM and E. coli CM.
Evolutionary relationship between E. coli CM and YCM
It has been noted earlier that the dimer of E. coli CM can
be superimposed onto a monomer of YCM, indicating a
common evolutionary origin of the two enzymes. [17,18].
Here, we discuss the relationship between the two CMs
in the light of more recent data on the allosteric transi-
tion. The CM domain (N-terminal 109 residues) of the
E. coli P protein consists of three helices H1–H3. Two
fragments of the E. coli CM domain dimerize such that
two active sites are formed between a four-helix bundle
of H1, H2, H3 and H1′ (where H′ represents helices from
the adjacent monomer; Figure 6). In YCM, helices H2,
H4, H7, H8, H11 and H12 correspond to H1′, H2′, H3′,
H1, H2 and H3 in E. coli CM. Thus, in YCM helices H2,
H4, and H7 are related by a common origin to helices
H8, H11 and H12, indicating a gene duplication event in
the evolution of YCM.
A superposition of YCM and E. coli CM shows that the
helices forming the active site in YCM are most conserved
between the two enzymes (Figure 6a). Also, the position
and binding mode of the endo-oxabicyclic inhibitor are
very similar. Thus, this region of the yeast enzyme corre-
sponds largely to one monomer of E. coli CM (Figure 6a;
red) and the structures superimpose well. A region com-
posed of 94 residues has an rms difference of 1.06 Å
between the two CMs and shows 22% sequence identity
[18]. The main difference between the enzymes in this
region is the presence of the partially disordered 220s loop
in YCM, which probably plays a role in the allosteric regu-
lation. The other monomer of the bacterial CM has
become more diverged in YCM. The region around the
second active site of E. coli CM is significantly reduced in
YCM. The loop between helices H7 and H8, the loop
which forms the connection between the two gene-dupli-
cated pre-domains in YCM, and part of the 50s loop are
close to the location of the ‘former’ second active site.
Helix H2′ of E. coli CM and H4 in YCM have diverged
significantly such that H4 forms the regulatory domain in
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Table 2
Selected distances (Å) between tyrosine or tryptophan and residues of the regulatory site.
Ligand atom Protein atom ITYR* TYR ITRP STRP TRP*
N O, AsnB138 2.8 3.8 3.4 3.3 3.3
Oδ1, AsnB139 3.3 3.5 3.3 3.4 3.2
Oγ, SerB142 3.3 2.4 2.9 3.0 2.8
O N, GlyB141 2.7 2.8 2.7 2.9 3.0
N, SerB142 2.9 2.8 3.6 3.1 3.0
O′ Nη, ArgA75 4.2 3.2 4.9 5.0 5.0
Nε, ArgA75 5.6 2.7 5.1 5.0 5.0
OH Nε, ArgA76 3.2 3.3 – – –
Oγ1, ThrB145 3.2 3.1 – – –
*Distances have been averaged over the two independently refined monomers in the asymmetric unit.
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Evolutionary relationship between E. coli CM and YCM. 
(a) Superposition of the dimer of E. coli CM onto the monomer of
YCM (see materials and methods). The two monomers of E. coli CM
are colored red and magenta. The catalytic and regulatory domains
of YCM are shown in blue and cyan, respectively. Also shown are
tryptophan (black) bound to the two regulatory binding sites in YCM,
the endo-oxabicyclic inhibitor bound to YCM in green and bound to
the two active sites of the E. coli CM dimer in black. (b) E. coli CM
dimer with the endo-oxabicyclic inhibitor (in green) bound to both
active sites. The twofold rotation axis relating the two monomers
(yellow and red) is shown as a black line. (c) Constructed tetrameric
molecule of two E. coli CM dimers derived from a superposition onto
the YCM dimer (not shown). Only those models for the inhibitor
which are bound to the conserved active sites between E. coli CM
and YCM are shown in green. The binding sites for the allosteric
effectors in YCM are marked by models for tryptophan shown in
blue. The local dimer axes of the E. coli dimers are shown as short
black lines, the allosteric rotation axis of YCM is marked as a long
black line. The view is along a twofold rotation axis relating the two
dimers of the constructed molecule. (d) YCM dimer viewed along the
dimer axis in the same orientation as the constructed tetramer. The
two halves of each monomer are colored red or yellow, based on the
corresponding monomers of the E. coli dimer.
YCM (Figure 6a; cyan). In addition, the long 50s and 80s
loops, which also belong to the regulatory domain have
formed, flanking H4.
E. coli CM has a much simpler fold and structure than YCM
and also lacks allosteric regulation, so it may be assumed
that the evolutionary precursor of the two enzymes was
similar to E. coli CM. From this ancestral protein, which
may also have been a dimer like E. coli CM, YCM has
evolved by gene duplication, allowing for the formation of
the regulatory domain, and by dimerization (or by tetra-
merization if the oligomerization event preceded the gene
duplication). Figures 6b–d illustrate the formal construc-
tion of a tetrameric molecule from the E. coli CM dimer, if
each dimer is superimposed onto one monomer of YCM.
The tetramer has a symmetry that is related to D2 (or 222,
having three perpendicular twofold axes). The two twofold
dimer axes of each E. coli dimer are not aligned, but are
parallel at a distance of 7 Å in the projection shown in
Figures 6b–d. The allosteric rotation axis, around which
the catalytic subunits rotate in the T→R transition,
forms an angle of 46° to these local twofold axes of each
E. coli dimer. The two parallel dimer axes are approxi-
mately in the same plane perpendicular to the YCM dimer
axis if the tetramer is constructed for the T state structure,
whereas the ~20° rotation around the allosteric axis tilts
the two axes by 10° in opposite directions relative to the
paper plane in the R state tetramer. For orientation, the
binding sites for the allosteric effectors at the YCM dimer
interface and for the active sites are also marked in the
constructed tetramer in Figure 6b. The long helices H1
and H1′ of each E. coli CM dimer form the four-helix
bundle at the dimer interface of YCM (two H2 and two
H8). A comparison to the structure of the YCM dimer also
demonstrates that mostly one half (red-colored) of each
monomer in YCM have changed to form the regulatory
subunit at the dimer interface.
Enzyme mechanism
Structures of YCM in complex with the endo-oxabicyclic
inhibitor showed similar binding of this transition-state
analogue to the active site of YCM to that in the homolo-
gous active site of E. coli CM (Figure 3). A significant dif-
ference between the two active sites is the interaction of
the ether oxygen of the substrate with Gln88 in E. coli CM
compared with Glu246 in YCM. Although both sidechains
are capable of similar hydrogen-bonding interactions, only
the glutamate sidechain might have a role as a general acid
in the reversible protonation of the ether oxygen, a mech-
anistic possibility discussed previously in the absence of
structural data [10]. Mutation of Glu246 to a glutamine
resulted in an enzyme which had an around sevenfold
reduced kcat but also a higher substrate affinity such that
kcat/Km of the mutant was similar to that of the activated
wild-type enzyme [19]. In contrast to wild-type YCM,
which has a narrow pH profile with optimum activity at
pH 5.5, the Glu246→Gln mutant has activity between pH
4 and 10 with no well-defined optimum. On the other
hand, the Gln88→Glu mutant of E. coli CM has kinetic
properties which are similar to the activated yeast enzyme
[24]. Thus, the conserved active sites of the two CMs and
the similar properties of the glutamate/glutamine mutants
indicate that both enzymes do not stabilize significantly
different transition states. The fact that wild-type YCM
and the Gln88→Glu mutant of E. coli CM have higher kcat
constants than the respective enzymes with a glutamine
residue suggests that a better transition-state stabilization
is achieved with a glutamate sidechain, possibly involving
a transient protonation step, or repulsion of the leaving
ether oxygen. This advantage is compensated by the
lower substrate affinity of these enzymes and a restriction
of the activity to acid pH.
In addition, a conjugation of the pi-electrons of the two
carboxylate groups of the substrate with the pi-electrons
of the chair-like transition state might reduce the activa-
tion energy. Both carboxylate groups of the inhibitor are
approximately positioned for such an interaction by the
two arginine sidechains (residues 16 and 157). However,
due to the different hybridization of C1 and C8 (sp3 in
the inhibitor and sp2 in the presumed transition state),
the inhibitor is not a perfect transition-state analogue to
study this interaction.
Structural studies on the three CMs of B. subtilis, yeast and
E. coli as well as many biochemical studies indicate that
these enzymes largely catalyze the pericyclic rearrange-
ment by two ways. Firstly, binding of the active pseudo-
diaxial conformation of the substrate to the active site is
achieved by polar interactions of the substrate’s carboxy-
late and hydroxyl groups with the enzyme. This has been
suggested previously following interpretation of an inverse
secondary isotope effect at C4 of chorismate [10] and on
the basis of the structure of B. subtilis CM [16]. Secondly,
the transition state of the reaction is stabilized by hydro-
gen-bonding interactions between polar sidechains and
the ether oxygen of the substrate. In all three enzymes, a
positively charged residue might stabilize a developing
negative charge on the ether oxygen. A development of
negative charge on the ether oxygen occurs if the con-
certed rearrangement is asynchronous, such that breakage
of the C–O bond is faster than formation of the C–C bond
[25]. A role of electrostatic interactions in the stabilization
of the transition state of the pericyclic reaction was pro-
posed earlier for B. subtilis CM [13] and confirmed on the
basis of the complex between the enzyme and the endo-
oxabicyclic inhibitor [16].
Allosteric pathway
Tyrosine has polar contacts to both subunits, which con-
tribute residues to a regulatory binding site; it forms
hydrogen bonds with Arg75 and Arg76 of the 80s loop of
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one monomer and to five residues of helix H8 of the
other monomer (Figures 5 and 7). The phenolic OH
group and the amino acid groups are involved in these
interactions. These polar interactions are assumed to
bring the regulatory domain and the catalytic domain of
the neighboring monomer closer together than in the
unliganded wild-type enzyme, for which no crystal struc-
ture is yet available, however. Tryptophan binds in a
very similar way as tyrosine, such that the amino and car-
boxylate groups and the five-membered ring of the tryp-
tophan sidechain are very close to the position of the
amino and carboxylate groups and the phenolic sidechain
of tyrosine, respectively (Figure 5c). Tryptophan, however,
makes polar interactions through its amino acid groups
only with residues of helix H8. The presence of the six-
membered ring of tryptophan pushes the 80s loop and
the regulatory domain away from helix H8. A major
factor in the initiation of allosteric movements to the R
state seems to be the steric interaction of the six-mem-
bered ring with the sidechain of Ile74. In contrast to
interactions with tyrosine in the R state structure, Arg75
and Arg76 have no polar interactions with tryptophan,
but van der Waals interactions might exist.
Binding of tryptophan causes a rotation of the two cat-
alytic domains by 15° relative to their position in the tyro-
sine-bound T state. The allosteric rotation axis is perpen-
dicular to the dimer axis (Figure 1). The regulatory domain
does not follow this rotation. Instead, this domain moves
in the other direction, away from the effector-binding site.
As a result of the rotation of the two catalytic domains,
many interactions at the dimer interface are rearranged.
These changes at the dimer interface cause further move-
ments within the catalytic domain that transmit the
allosteric signal to the catalytic site.
Figures 8 and 9 show such a putative allosteric pathway
from the dimer interface to the catalytic site. The con-
formational changes originate from the four residues
Tyr212, Tyr212′, Phe28 and Phe28′, which interact with
each other at the subunit–subunit interface. In the R-state
structure (ITRP, white carbons in Figure 8), the
sidechain of Tyr212 points towards the active site and
interacts with Asp24 of H2, which in turn is hydrogen
bonded to Lys208 of the neighboring helix H11. Glu23,
the residue next to Asp24, interacts with Arg204 of H11.
Arg157 is free to bind a carboxylate group of the
substrate, as seen in the enzyme–inhibitor complex in
ITRP (Figure 3); Glu23 is 6.6 Å away from the substrate’s
carboxylate group. In the T state, Tyr212 has a different
sidechain conformation — Tyr212 and Tyr212′ move
between the two phenylalanine residues (residues 28 and
28′) at the dimer interface. Thereby Phe28, which in the R
state is closer to the dimer interface, is together with this
part of helix H2 pushed toward the active site. As a result,
Asp24 and Glu23 of helix H2 also move closer to the active
site and change their partners for salt bridges — Asp24
now interacts with Arg204. The carboxylate group of
Glu23, which was previously interacting with Arg204 in
the R state, in turn moves by 5.0 Å into the active site to
interact with Arg157 in the T state. If the inhibitor were
present in this structure at the same position as in the R-
state structure, the carboxylate group of Glu23 would be
only 3.2 Å away from the substrate’s carboxylate group.
Thus, the conformation of Glu23 in the T-state structure
probably strongly affects substrate binding. Moreover,
Arg157 interacts with substrate less favorably and with less
effective charge in the T state. Other active-site residues,
including Lys168 and Glu246 shown in Figure 8, show
only minor differences between T and R state structures.
Although other residues at the dimer interface also have
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Figure 7
Interactions at the regulatory site in relation to
the allosteric transition. Tyrosine (left) induces
the T state by polar interactions to both sides
of the dimer interface that bring H4/L80s and
H8 closer together. Tryptophan (right) pushes
the two monomers apart and causes a
rotation of the two subunits to the R-state
structure.
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different conformations or interactions in the T and R
state structures, there are no other examples in which
these changes appear to be transmitted toward the active
site, causing significant differences.
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Figure 8
A proposed allosteric pathway between the
dimer interface and the active site shown in
stereo. Selected residues of ITRP (white
carbons) and TYR (green) are superimposed.
The two structures were superimposed based
on residues of the catalytic domain of one
monomer of the YCM dimer (see Materials
and methods). The black line at the top of the
figure marks the dimer axis in ITRP.
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Figure 9
Conformational changes of Phe28 and
Tyr212 between (a) T state (TYR) and (b) R
state (ITRP) in relation to the allosteric
pathway. The view is along the allosteric
rotation axis perpendicular to the dimer axis
(both axes are shown), similar to Figure 2. For
reference, the endo-oxabicyclic inhibitor is
shown in the T-state structure at a position
derived from a superposition of the catalytic
domain with ITRP.
The allosteric pathway we propose here does not include a
direct connection between the regulatory site and the
active site. Instead, binding of the effector causes a rota-
tion of the monomers relative to each other, which is a
typical feature of allosteric transitions of multimeric pro-
teins. The long helix H8, which spans the whole monomer
and extends from the regulatory site to the active site,
probably serves as a lever by which tryptophan can initi-
ate the rotation of the catalytic domain (Figure 9). This
rotation causes conformational changes at the interface
between the rotating monomers, which are then transmit-
ted to the active site. Thus, the rotation of subunits
serves as a means to transmit conformational changes
from the regulatory site to any point at the subunit inter-
face. The distance between the effector and Tyr212 is
∼20 Å in YCM. The allosteric interaction between active
sites (homotropic cooperative effect) could be transmit-
-ted along the same pathway, across the dimer interface.
Tyr212 and Phe28 are at a special position at the dimer
interface, because they are directly next to the dimer axis
and all four residues (212, 212′, 28 and 28′) interact with
each other between subunits. Interestingly, Tyr212 is
also the first residue of the partially disordered 220s loop
(residues 212–226), which probably has an important role
in the allosteric transition (see above). The conformation
of this loop might influence the conformation of Tyr212.
The X-ray structures of YCM in complex with the endo-
oxabicyclic transition state analogue inhibitor showed the
enzyme in a state in which the monomers are rotated rel-
ative to each other by about 22° with respect to the T
state (0° rotation). The enzyme is present in this super R
state even when the allosteric inhibitor tyrosine is bound
to the regulatory site. Thus, it seems likely that this 
is the catalytically active state. Binding of tryptophan
brings the enzyme, by a rotation angle of 15°, close to
this active state, whereas the tyrosine-bound enzyme
structure defines the T state (0° rotation, by definition).
Binding of tryptophan activates YCM ~10-fold, whereas
tyrosine inhibits the enzyme by about the same factor.
Thus, the structure of the enzyme in the absence of effec-
tors might be expected to have a rotation angle between
0° and 15°. Alternatively, the three states determined so
far are the only stable minima along the transition from
the T state to the active super R state, and the kinetics
of the unliganded enzyme are a result of an equilibrium
among these three different states.
In addition, the super R state structure of ITYR suggests
that the T state structure as seen in TYR might show
extremely low activity, but requires the transformation to
the R state for effective catalytic turnover. The different
kinetic behaviour (Km is increased by a factor of 30 in the
T state compared to the R state) is caused by a conforma-
tional change of the protein to the R state preceeding the
catalytic step. The induction of R-state structures by both
the allosteric activator as well as a transition-state analogue
are in agreement with the heterotropic and homotropic
allosteric behavior of the enzyme.
As the binding of relatively small ligands induces these
conformational changes along the allosteric pathway, it
might be expected that other forces, such as crystal-
packing interactions, might especially influence the struc-
tures of allosteric proteins. Although this possibility
cannot be excluded here as in other similar studies, the
similarity of the R-state structures TRP and STRP, which
were crystallized in different space groups, argues against
this possibility.
Biological implications
Chorismate mutase (CM) catalyzes the conversion of
chorismate to prephenate, the first committed step in the
biosynthesis of the aromatic amino acids tyrosine and
phenylalanine. The enzyme is allosterically regulated in
two ways — feedback inhibition by tyrosine and activa-
tion by tryptophan. Tryptophan is the product of the
other branch of the synthesis of aromatic amino acids,
which begins with the conversion of chorismate to
anthranilate by anthranilate synthase. As a relatively
small allosteric protein, yeast chorismate mutase pro-
vides an ideal model system for exploring the detailed
mechanisms of allosteric regulation. The reaction mech-
anism involving the Claisen rearrangement of choris-
mate to prephenate, notably the only known example of
an enzyme-catalyzed pericyclic reaction, has also raised
considerable interest in these enzymes. The design of
inhibitors on the basis of structural information on cho-
rismate mutases, which are present in archaebateria,
eubacteria, plants, yeast and fungi, but not in humans
and animals, has the potential for the development of
new bacteriocides, herbicides and fungicides.
Our studies on the crystal structures of dimeric yeast
CM in the inactive T and active R states and with a
bound transition state analogue inhibitor define the
structural changes between the two allosteric states and
their influence on the active-site structure. Binding of
the allosteric effectors to the regulatory-binding site at
the dimer interface causes rotations of the catalytic
domains, such that in the R state the monomers are
rotated 15° relative to each other (where 0° rotation
defines the T state). In the presence of the transition-
state analogue, a super R state is formed, the monomer–
monomer angle of which differs by 22° from the T state.
The interactions between the effectors and residues at
the regulatory site which cause these rotations in differ-
ent directions are characterized. Tyrosine keeps the
two subunits close together at a contact point between
helix H8 and the 80s loop, by forming polar interactions
with both these structural elements. Tryptophan pushes
the subunits apart due to the larger size of its additional
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six-membered ring. An allosteric pathway is proposed
that links conformational changes at the dimer interface
resulting from the rotation of subunits to changes in the
active site, involving residues Tyr212, Phe28, Asp24,
Glu23, Lys208 and Arg204.
Rotations of subunits are a typical feature of the
allosteric transition of multimeric proteins by which
conformational changes can be transmitted over long
distances from the effector-binding site to any point at
the subunit interface. The present study reveals struc-
tural insight into the function of such an allosteric
pathway on a molecular level. This model for the
mechanism of the allosteric transition is subject to further
studies, especially those on suitable mutant enzymes.
In addition, the detailed structural characterisation of
the allosteric pathway forms the basis for a broader
understanding of the mechanisms of allosteric regula-
tion, for example by enabling an analysis by other
means such as computational methods.
Binding of an endo-oxabicyclic transition state analogue
inhibitor to yeast CM confirms the postulated binding
mode, based on the distant relationship with E. coli cho-
rismate mutase, and allows for an analysis of the inter-
actions which stabilize the transition state of the cat-
alytic reaction. Binding of the substrate as the pseudo-
diaxial conformer, which is required for the pericyclic
reaction, and transition-state stabilization by electrosta-
tic interactions, particularly of the ether oxygen of the
substrate which develops a partial negative charge  in
the course of a concerted but asynchronous reaction,
are the main factors for the 106-fold rate enhancement
by the wild-type enzymes over the uncatalyzed reaction.
Materials and methods
Crystallization and data collection
Wild-type and mutant YCM were isolated as described previously
[3]. Crystals were grown by the hanging-drop method. For the R32
crystal form of ITRP, the protein solution was equilibrated against a
solution of 19 % (w/v) polyethyleneglycol monomethylether 5000,
5 mM dithiothreitol, 0.15 M Tris HCl, pH 8.0, 0.15 M sodium acetate
and 16 mM tryptophan. For ITYR, the reservoir contained 32% (w/v)
polyethyleneglycol monomethylether 550, 4 mM dithiothreitol, 0.1 M
Tris HCl, pH 9.0, 0.1 M sodium chloride and 2 mM tyrosine. The
drops contained at the beginning of the vapor diffusion crystallization
procedure approximately 10 mg/ml protein, 3 mM endo-oxabicyclic
inhibitor and half of the reservoir buffer concentration. Rhombohedral
crystals of size 0.3 × 0.3 × 0.3 mm3 grew within about one week.
For the C2 crystal form of the Thr226→Ser mutant, the protein solution
was equilibrated against a solution of 19% polyethylene glycol 3350,
3 mM dithiothreitol, 0.16 M sodium acetate, pH 5.0, and 16 mM trypto-
phan. The drop contained ~10 mg/ml protein and half of the concentra-
tion of the reservoir buffer. Plate-like crystals of size 0.8 × 0.8 × 0.2 mm3
appeared within one week.
Data for the two R32 crystal forms were collected at –150°C from
crystals mounted in a hair-loop free-standing film of a cryo-buffer con-
taining glycerol. The crystals were transferred stepwise to solutions
containing increasing amounts of glycerol in the reservoir buffer until a
final concentration of 20% (v/v) glycerol was reached. X-ray diffraction
data for the C2 crystals were collected in a sealed capillary at room
temperature. Table 3 summarizes the details of data collection on a
Siemens (Madison, WI) model X-1000 multiwire area detector and of
data reduction with the program XDS [26].
Structure determination and refinement
The three structures were solved by molecular replacement (program
AMORE [27]) using the model for YCM in the R state as the search
model. Crystallographic refinement was performed using X-PLOR [28]
by several rounds of manual rebuilding (program O [29]), simulated
annealing and positional minimization. The R32 crystal form contains
two independent monomers in the asymmetric unit which belong to dif-
ferent protein dimers. For ITRP at 3.0 Å resolution, strict non-crystallo-
graphic symmetry restraints were employed. Refinement of the two
monomers independently with energy-based restraints yielded higher
Rfree values after refinement. For ITYR, however, independent refine-
ment of the two monomers with ncs-restraints resulted in better R
values. Restraints were employed on the mainchain and sidechains
atoms except for those involved in crystal contacts. STRP contains one
subunit in the asymmetric unit. 85 water molecules were included man-
ually from Fo–Fc difference electron maps for STRP.
The exogenous ligands were introduced into the model, when the
protein model was already well refined and the density of the effec-
tors and the inhibitor was clear. For all ligands there was strong
density present at the corresponding binding sites which could be
readily interpreted. For ITRP the endo-oxabicyclic inhibitor was
refined to relatively high B values which are usually only observed for
disordered residues (Table 3). The electron density maps, even
before the inhibitor was introduced into the model, were well defined
and clearly demonstrated binding of this inhibitor, however. The high
B values could be a result of some positional disorder of the ligand,
possibly also between the two subunits which, because of the limited
resolution, were not refined independently. Other causes might be a
partial occupancy of the ligand or an artifact resulting from the rela-
tively low resolution data.
In addition to those programs mentioned above, programs of the CCP4
suite [30] were used for the crystallographic analysis. All non-schematic
figures were calculated using program BOBSCRIPT (R Esnouf, Leuven,
Belgium), which is derived from program MOLSCRIPT [31].
Superpositions
The matrices for a superposition of different models or regions were
calculated by a least-squares distance minimization algorithm imple-
mented inside the program O [29] using Cα atoms. For the superposi-
tion of the whole monomer or dimer of different YCM models residues
1–214 and 224–256 were used. Residues 6–43, 108–211, and
231–251 were used for the alignment of the catalytic domains. The
dimer of E. coli CM was superimposed onto a YCM monomer using
residues 13–27, 146–171, 192–211, and 238–252 of YCM and
B8–B22, A17–A42, A46–A65, and A80–A94 of E. coli CM.
Accession numbers
Structure coordinates were deposited with the Brookhaven Protein
Data Bank with the codes 3csm, 4csm and 5csm for the ITRP, ITYR
and STRP structures, respectively.
Note added in proof
A very recent molecular dynamics study of docking of the endo-oxabi-
cyclic transition-state analogue to the YCM molecule finds that
Glu246 is hydrogen bonded to the ether oxygen via a water bridge,
rather than directly (Lin, S.L., Xu, D., Li, A., Rosen, M., Wolfson, H.J. &
Nussinov, R. (1997). Investigation of the enzymatic mechanism of the
yeast chorismate mutase by docking a transition state analog. J. Mol.
Biol. 271, 838–845). The refined structures ITRP and ITYR of the
present study, however, show the Glu246 sidechain in close dis-
tance to the ether oxygen.
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